Accessed 04 Sept 2023
To help you feel and look better
A Sanofi spokesperson told BioSpace in an emailed statement that the company made the strategic decision of focusing on offering the combination therapy Soliqua consisting of GLP-1 and basal insulin to help people manage their diabetes. The spokesperson added that Soliqua has since become one of the cornerstone therapies in its diabetes portfolio and represents an important growth asset for the company
If youre using Tirzepatide for weight loss, you already know how effective it can be: appetite drops, fat loss accelerates, and blood sugar becomes far more predictable
Management of obesity and type 2 diabetes using GLP-1 agonist Our Medically Supervised Weight Loss Program at Aesthetics & Medical Lasers of Colorado uses a medication that mimics the bodys natural weight control hormone called Glucagon like peptide- 1 (GLP-1)
Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE